Medications

Aprotinin is effective in COVID-19 patients

A clinical study from Spain recently confirmed laboratory experiments made by researchers of Goethe University Frankfurt and University of Kent who showed that the protease inhibitor aprotinin prevented cells to be infected ...

Diseases, Conditions, Syndromes

T-cells: The superheroes in the battle against omicron

Omicron is spreading rapidly throughout the world, with experts claiming that 40% of the global population will be infected within the next two months. This sounds quite startling, but we still don't really know whether omicron ...

Diseases, Conditions, Syndromes

XBB.1.5, the most transmissible Covid subvariant yet

The Omicron subvariant XBB.1.5, the most transmissible COVID-19 subvariant so far, is spreading quickly across the United States and was predicted on Friday to become Europe's dominant strain in a matter of weeks.

Diseases, Conditions, Syndromes

Promising developments in pursuit to design pan-coronavirus vaccine

Researchers at the Francis Crick Institute have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common ...

Diseases, Conditions, Syndromes

Scientists develop test that easily detects variants causing COVID-19

Rutgers scientists have developed a lab test that can quickly and easily identify which variant of the virus causing COVID-19 has infected a person, an advance expected to greatly assist health officials tracking the disease ...

page 10 from 17